*Some Market data delayed by 15 mins.

89bio, Inc. Common Stock

Symbol: ETNB (NASDAQ)
0.00 ▼ (-100.00%) -8.940

Company Description:
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $8.94
  • Yesterday High: $9.1
  • Yesterday Low: $8.51
  • Yesterday Volume: 507.14K
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: 89bio, Inc. Common Stock
  • Website: https://www.89bio.com
  • Listed Date: 2019-11-11
  • Location: SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001785173
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $879.55M
  • Round Lot: 100
  • Outstanding Shares: 98.38M
  • Asset Type: CS
RECENT FILINGS FOR ETNB
Filing DateFiling TypeFormat
2024-05-0910-QView
2024-05-098-KView
2024-05-034View
2024-04-233View
2024-04-19ARSView
2024-04-17DEFA14AView
2024-04-17DEF 14AView
2024-04-178-KView
2024-04-154View
2024-04-108-KView
2024-04-034View
2024-04-01144View
2024-03-08S-8View
2024-03-06SC 13D/AView
2024-03-064View
2024-03-01NT 10-KView
2024-03-0110-KView
2024-02-298-KView
2024-02-284View
2024-02-26144View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.